Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life.

ABSTRACT:

Background

A multistakeholder core outcome set created for asthma trials showed that asthma-specific quality of life (QoL) was a critically meaningful outcome. However, the definition and measurement methods were undetermined. The adverse effects (AEs) of corticosteroids may be a vital clinical trial outcome. Nevertheless, the AE burden from the patient perspective has not yet been elucidated in an asthma population.

Objective

To characterize patient burden of AEs in oral (OCS) and inhaled corticosteroids (ICS) and how this relates to QoL within an asthma population.

Methods

We used a convergent parallel mixed-methods design with quantitative surveys of known ICS and OCS AEs that were distributed through the Allergy & Asthma Network database, social channels, and the

SUBMITTER: Persaud PN 

PROVIDER: S-EPMC10843134 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature